Capricor Therapeutics CAPR
NASDAQ CAPR
$8.94 -0.53 (-5.60%)
At close: Oct 1, 2026 · 4:00 PM EDT

Capricor Therapeutics (CAPR) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Capricor Therapeutics' Depreciation & Amortization (CF) came in at $561,845 for Q2 2026, up 15.5% from $486,278 a year earlier and up 5.1% from the prior quarter.

Analysis

Capricor Therapeutics (CAPR) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Capricor Therapeutics reported Depreciation & Amortization (CF) of $2.09 million, up 28.6% year-over-year; for FY2025, it was $1.89 million, up 32.5% from FY2024.

  • Depreciation & Amortization (CF) has increased in each of the last five years, with a five-year compound annual growth rate of 67.4% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $1.43 million in FY2024 (+33.3%), $1.07 million in FY2023 (+100.5%), $533,131 in FY2022 (+117.0%) and $245,697 in FY2021 (+70.8%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2010.
  • Year-over-year, Depreciation & Amortization (CF) has increased for 22 consecutive quarters, with growth averaging 28.7% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Depreciation & Amortization (CF) ranged from 15.5% (Q2 2026) to 148.8% (Q1 2023).
  • Business Quant data shows CAPR's Depreciation & Amortization (CF) at $534,670 (Q1 2026), $502,587 (Q4 2025) and $494,726 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Capricor Therapeutics 550.29 Mn 550.29 Mn - 561,845.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 561,845.00
Mar 31, 2026 534,670.00
Dec 31, 2025 502,587.00
Sep 30, 2025 494,726.00
Jun 30, 2025 486,278.00
Mar 31, 2025 405,450.00
Dec 31, 2024 375,705.00
Sep 30, 2024 361,168.00
Jun 30, 2024 356,935.00
Mar 31, 2024 331,406.00
Dec 31, 2023 307,608.00
Sep 30, 2023 276,471.00
Jun 30, 2023 254,702.00
Mar 31, 2023 230,101.00
Dec 31, 2022 191,602.00
Sep 30, 2022 137,028.00
Jun 30, 2022 112,011.00
Mar 31, 2022 92,490.00
Dec 31, 2021 78,645.00
Sep 30, 2021 64,720.00
API Access

Capricor Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CAPR&period=max&api_key=YOUR_API_KEY